| Característica |
Objectiu de la convocatòria
This grant program supports research focused on identifying, characterizing, and developing approaches and techniques for the early detection or prevention of lung cancer, while gaining insight into pre-neoplastic processes in the lungs. The ultimate goal is to detect lung cancer at the earliest stages and improve survival and survivorship.
|
Característiques principals
Project topics include, but are not limited to:
Improvements in risk stratification of patients and uptake for screening
Identification and characterization of new biomarkers for NSCLC and SCLC
Development of predictive, diagnostic, or prognostic biomarkers
Liquid biopsy assays and related techniques
Genomic and histological approaches to improve early detection in tissue samples
Novel imaging and computational modalities to identify and risk stratify pre-neoplastic lesions
Implementation science with systematic uptake of evidence-based research findings into routine practices to improve quality and effectiveness of health services for early detection
Studies of pre-neoplasia and progression to lung neoplasia to inform prevention strategies
Development of pathways to increase uptake and utilization of lung cancer screening
Epidemiology studies to identify risk factors and implementation of prevention measures
Development of any new technologies that will aid in identifying early-stage lung cancers
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Júlia Vidal: [email protected] Ext.: 1736
|
Convocatòria (URL)
https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2026/
|
Informació addicional
All applications for funding must be submitted online at Proposal Central through a two-stage process consisting of a letter of intent (LOI) and full proposal.
|
Requisits
Investigators must be primarily affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than seven years' experience since their initial faculty appointment. Exceptions may be granted for investigators with more years of experience in other disease areas or research topics.
Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.
Applicants who have received or are receiving LCRF funding in the last four years are not eligible to apply.
Applicants may submit only one LCRF grant application per award cycle either as lead investigator or co-investigator.
Senior investigators with more than seven years' experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process.
|
Dotació
USD 75,000 per year
|
Durada
Two years
|